Simplex Trading
AGRX

Simplex Trading’s Agile Therapeutics AGRX Stock Holding History

Simplex Trading’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3
Closed -$9K – 11774
2021
Q3 		$9K Hold
3
– – ﹤0.01% 9021
2021
Q2 		$9K Buy
+3
New +$9.89K ﹤0.01% 9188
2021
Q1 		– Hold
0
– – – 7689
2020
Q4 		– Hold
0
– -$36K – 9319
2020
Q3 		– Hold
0
– – – 5921
2020
Q2 		– Hold
0
– – – 6125
2020
Q1 		– Hold
0
– – – 5810
2019
Q4 		– Hold
0
– – – 5434
2019
Q2 		– Hold
0
– -$2K – 8038
2019
Q1 		– Hold
0
– – – 6836
2018
Q2 		– Hold
0
– -$1K – 8057
2018
Q1 		– Hold
0
– – – 5875
2017
Q4 		– Hold
0
– – – 4035

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading's AGRX Position: Q2 2022 in Review

Simplex Trading held its Agile Therapeutics (AGRX) position steady in Q2 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #11546.

Simplex Trading first reported a position in AGRX in Q3 2017 and has held it in 8 quarters since. The position peaked at $39K in Q4 2019. 19 funds tracked by Wall St. Rank hold AGRX as of Q2 2022.

  • Simplex Trading held 0 shares of Agile Therapeutics worth $0 as of Q2 2022.
  • Simplex Trading left its Agile Therapeutics share count unchanged in Q2 2022.
  • Agile Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2022, its #11546 holding.
  • Simplex Trading first reported a position in Agile Therapeutics in Q3 2017 and has held it in 8 quarters since.
  • Simplex Trading's Agile Therapeutics position peaked at $39K in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.